Despite Apple's robust security measures, iPhones aren't completely immune to malware threats. While traditional viruses are rare on iOS devices, sophisticated malware, spyware, and malicious ...

Prioritization of refractory rheumatoid arthritis (RA) as lead indication for AlloNK® development FDA Fast Track Designation received for AlloNK ...

Bell is preparing to launch its direct-to-cell satellite service, promising full mobile connectivity for Canadians in remote ...

Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV, FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, today announced that new ...

Quasar 2 represents a breakthrough in redefining the role of the electric vehicle. With these first installations now live, Wallbox is preparing for broader U.S. availability. The company's goal is to ...

MICVO received Fast Track Designation from the U.S. Food and Drug Administration for the treatment of adult patients with R/M HNSCC whose disease has progressed following treatment with platinum-based ...

Populations Insights for GEO-CM04S1 in Immunocompromised Patients. ATLANTA, GA - October 9, 2025 (NEWMEDIAWIRE) - GeoVax ...

Prioritization of refractory rheumatoid arthritis (RA) as lead indication for AlloNK® development FDA Fast Track Designation received for AlloNK in refractory RA, representing the first drug candidate ...

In the past few weeks, several major stories have emerged that are seismically shaking up the cellular industry, with impacts ...

RetinalGenix Technologies Inc.[OTCQB: RTGN] ('RetinalGenix” or the 'Company”), a company developing ultra-high-resolution ...

Equity Insider News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 15, 2025/CNW/ — Eight new oncology approvals between July and September 2025 marked a pivotal quarter ...

EMBL researchers and collaborators have developed SDR-seq, a breakthrough single-cell technology that captures DNA and RNA ...